PGI5 COST-EFFECTIVENESS OF NATALIZUMAB IN CROHNS DISEASE PATIENTS WHO HAVE FAILED ANTI-TNF ALPHA THERAPY
May 1, 2008, 00:00
10.1016/S1098-3015(10)70277-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)70277-1/fulltext
Title :
PGI5 COST-EFFECTIVENESS OF NATALIZUMAB IN CROHNS DISEASE PATIENTS WHO HAVE FAILED ANTI-TNF ALPHA THERAPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70277-1&doi=10.1016/S1098-3015(10)70277-1
First page :
Section Title :
Open access? :
No
Section Order :
930